Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Rebora

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Pharmaceutical Statistics|October 2, 2012
Sample size calculation for recurrent events data in one-arm studiesPaola Rebora, Stefania Galimberti
Statistical Methods in Medical Research|May 22, 2014
Survival estimation in two-phase cohort studies with application to biomarkers evaluationPaola Rebora, Maria Grazia Valsecchi
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|July 15, 2005
[Statistical notes. Randomized controlled clinical trials of both superiority and non-inferiority: critical considerations]Ettore Marubini, Paola Rebora, Giuseppe Reina
Giornale Italiano Di Cardiologia (2006)|June 7, 2006
[Statistical notes. Which risks do the patient incur if his own cardiologist accepts to be involved in a clinical trial without deep consideration of the a priori available evidence?]Ettore Marubini, Paola Rebora, Giuseppe Reina
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|April 13, 2005
[Statistical notes. Hazard curves of sudden death: their role in the cardiologist's clinical decision]Ettore Marubini, Paola Rebora, Giuseppe Reina
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|December 1, 2004
[Statistical notes. From superiority to non-inferiority clinical trials: a leap in the dark?]Ettore Marubini, Paola Rebora, Giuseppe Reina
Intensive Care Medicine|April 29, 2025
Persistent severe AKI is bad-where to go now?Zoltan Endre, Paola Rebora, Marlies Ostermann
Journal of the National Cancer Institute|May 15, 2008
Timing of familial breast cancer in sistersPaola Rebora, Kamila Czene, Marie Reilly
Intensive Care Medicine|August 3, 2020
The role of frailty in COVID-19 patientsGiuseppe Bellelli, Paola Rebora, Giuseppe Citerio
Aging and Disease|April 3, 2023
Response to Letter to the Editor, "Mechanical Ventilation in COVID-19 Patients: a question from Age to Frailty"Fiona Ecarnot, Paola Rebora, Giuseppe Bellelli, et al.
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Pharmaceutical Statistics|October 2, 2012
Sample size calculation for recurrent events data in one-arm studiesPaola Rebora, Stefania Galimberti
Statistical Methods in Medical Research|May 22, 2014
Survival estimation in two-phase cohort studies with application to biomarkers evaluationPaola Rebora, Maria Grazia Valsecchi
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|July 15, 2005
[Statistical notes. Randomized controlled clinical trials of both superiority and non-inferiority: critical considerations]Ettore Marubini, Paola Rebora, Giuseppe Reina
Giornale Italiano Di Cardiologia (2006)|June 7, 2006
[Statistical notes. Which risks do the patient incur if his own cardiologist accepts to be involved in a clinical trial without deep consideration of the a priori available evidence?]Ettore Marubini, Paola Rebora, Giuseppe Reina
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|April 13, 2005
[Statistical notes. Hazard curves of sudden death: their role in the cardiologist's clinical decision]Ettore Marubini, Paola Rebora, Giuseppe Reina
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|December 1, 2004
[Statistical notes. From superiority to non-inferiority clinical trials: a leap in the dark?]Ettore Marubini, Paola Rebora, Giuseppe Reina
Intensive Care Medicine|April 29, 2025
Persistent severe AKI is bad-where to go now?Zoltan Endre, Paola Rebora, Marlies Ostermann
Journal of the National Cancer Institute|May 15, 2008
Timing of familial breast cancer in sistersPaola Rebora, Kamila Czene, Marie Reilly
Intensive Care Medicine|August 3, 2020
The role of frailty in COVID-19 patientsGiuseppe Bellelli, Paola Rebora, Giuseppe Citerio
Aging and Disease|April 3, 2023
Response to Letter to the Editor, "Mechanical Ventilation in COVID-19 Patients: a question from Age to Frailty"Fiona Ecarnot, Paola Rebora, Giuseppe Bellelli, et al.
Pageof 16